ADAM23	a disintegrin and metalloprotease domain 23
ADLTE	autosomal dominant lateral temporal lobe epilepsy
AE	autoimmune encephalitis
AEDs	antiepileptic drugs
AMPA	α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
ANNA-1	antineuronal nuclear antibody type 1
APE	antibody prevalence in epilepsy
BBB	blood-brain barrier
Caspr2	contactin-associated protein-like 2
CNS	central nervous system
CRMP-5	collapsin response mediator protein-5
DPPX	dipeptidyl-peptidase-like protein 6
FBDSs	faciobrachial dystonic seizures
FLAIR	fluid-attenuated inversion recovery
GABA	ϒ-aminobutyric acid
GAD65	glutamic acid decarboxylase
GEFS+	generalized epilepsy with febrile seizures plus
HMGB1	high-mobility group box protein 1
HS	hippocampal sclerosis
HSV	herpes simplex virus
IL-1	interleukin-1
ILAE	International League Against Epilepsy
IFNγ	interferon gamma
IVIg	intravenous immunoglobulin
LE	limbic encephalitis
LGI1	leucine-rich glioma-inactivated protein 1
LPS	lipopolysaccharide
MOG	myelin oligodendrocyte glycoprotein
mTOR	mammalian target of rapamycin
NMDA	N-methyl-D-aspartate
NMDAR	NMDA receptor
NORSE	New-onset refractory status epilepticus
NR1	GluN1
PERM	progressive encephalomyelitis with rigidity and myoclonus
PET	positron emission tomography
PNS	peripheral nervous system
PNSs	paraneoplastic neurological syndromes
PRE	pharmacoresistant epilepsy
PTEN	phosphatase and tensin homolog
RITE	response to immunotherapy in epilepsy
TLE	temporal lobe epilepsy
TLR4	toll-like receptor 4
TNFα	tumor necrosis factor alpha
VGKC	voltage-gated potassium channel